Research ArticleCANCER TREATMENT

CHK1 as a therapeutic target to bypass chemoresistance in AML

See allHide authors and affiliations

Science Signaling  13 Sep 2016:
Vol. 9, Issue 445, pp. ra90
DOI: 10.1126/scisignal.aac9704

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Signaling


Editor's Blog

Navigate This Article